Skip to main content

Table 1 Comparison of clinical data and biochemical indicators among groups

From: Associations of plasma 8-iso-prostaglandin Flevels with fasting blood glucose (FBG) and intra-abdominal fat (IAF) area in various Glycometabolism populations

Variables NC group Prediabetes group New-onset
T2DM group
Non-new-onset
T2DM group
F P
N(M/F) 53 (27/24) 41 (22/19) 29 (16/13) 37 (18/19)
Age (year) 55.42 ± 9.71 57.59 ± 7.71 57.86 ± 9.27 58.67 ± 6.46 1.173 0.322
BMI (kg/m2) 25.53 ± 3.23 27.00 ± 2.73 25.73 ± 2.94 26.29 ± 3.31 1.691 0.171
SBP (mmHg) 119.42 ± 14.86 128.15 ± 15.77# 131.62 ± 15.90# 128.30 ± 14.74# 4.853 0.003
DBP (mmHg) 77.63 ± 10.83 81.06 ± 8.99 82.72 ± 12.41 78.43 ± 10.28 1.753 0.159
WC (cm) 89.25 ± 10.58 90.76 ± 8.52 89.78 ± 9.79 93.53 ± 7.72 1.614 0.189
HC (cm) 101.29 ± 8.31 102.71 ± 6.38 99.91 ± 6.44 99.45 ± 6.92 1.420 0.239
WHR 0.88 ± 0.06 0.88 ± 0.06 0.90 ± 0.05 0.94 ± 0.06#&* 9.518 0.000
TG (mmol/L) 1.77 ± 1.04 1.79 ± 0.98 1.76 ± 0.86 2.13 ± 1.91 0.720 0.542
TC (mmol/L) 5.29 ± 1.17 5.05 ± 0.94 5.41 ± 1.18 5.55 ± 1.57 1.028 0.382
HDL-C (mmol/L) 1.47 ± 0.36 1.37 ± 0.35 1.45 ± 0.32 1.26 ± 0.24#* 3.193 0.025
LDL-C (mmol/L) 2.78 ± 0.91 2.68 ± 0.71 2.75 ± 0.78 3.04 ± 1.07 1.158 0.328
FBG (mmol/L) 5.03 ± 0.49 5.49 ± 0.71 6.06 ± 1.19# 8.38 ± 2.85#&* 34.870 0.000
2hPG(mmol/L) 6.20 ± 1.11 9.24 ± 1.13# 13.76 ± 3.03#& 13.35 ± 5.22#& 57.991 0.000
FINS (mIU/L) 8.01 ± 4.42 8.91 ± 4.56 7.60 ± 3.11 8.76 ± 6.34 0.565 0.639
2 h INS (mIU/L) 32.13 ± 20.90 67.00 ± 57.71# 47.93 ± 23.94#& 31.45 ± 34.29&* 7.634 0.000
IAF area (cm2) 83.27 ± 41.55 99.50 ± 27.95 109.07 ± 43.93# 104.25 ± 33.94# 3.697 0.013
HOMA-IR 1.81 ± 1.04 2.18 ± 1.17 2.06 ± 1.00 3.93 ± 4.12#&* 6.987 0.000
8-iso-PGF2a(pg/ml) 32.28 ± 20.09 39.02 ± 21.72 42.22 ± 25.44# 50.06 ± 31.41# 3.688 0.013
  1. Abbreviations: BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, HC hip circumference, WHR waist-hip ratio, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FBG fasting blood glucose, 2hPG 2 h postprandial glycemia, FINS fasting insulin, 2 h INS 2 h insulin, IAF intra-abdominal fat, HOMA-IR homeostasis model assessment-insulin resistance, 8-iso-PGF2a 8-iso-prostaglandin F2a
  2. #,compared with NC group, P < 0.05; &,compared with prediabetes group, P < 0.05;*, compared with new-onset T2DM group, P < 0.05